Norinchukin Bank The increased its position in shares of Agilent Technologies, Inc. (NYSE:A) by 6.9% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 22,368 shares of the medical research company’s stock after acquiring an additional 1,440 shares during the period. Norinchukin Bank The’s holdings in Agilent Technologies were worth $1,327,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently made changes to their positions in the company. UBS Asset Management Americas Inc. raised its holdings in Agilent Technologies by 9.8% during the first quarter. UBS Asset Management Americas Inc. now owns 882,075 shares of the medical research company’s stock valued at $46,635,000 after buying an additional 78,851 shares in the last quarter. Teza Capital Management LLC bought a new position in Agilent Technologies during the first quarter valued at about $206,000. State of Wisconsin Investment Board raised its holdings in Agilent Technologies by 83.7% during the first quarter. State of Wisconsin Investment Board now owns 326,805 shares of the medical research company’s stock valued at $17,278,000 after buying an additional 148,866 shares in the last quarter. Stevens Capital Management LP raised its holdings in Agilent Technologies by 49.5% during the first quarter. Stevens Capital Management LP now owns 14,461 shares of the medical research company’s stock valued at $765,000 after buying an additional 4,788 shares in the last quarter. Finally, Buckingham Asset Management LLC bought a new position in Agilent Technologies during the first quarter valued at about $206,000.

Shares of Agilent Technologies, Inc. (A) opened at 65.96 on Friday. Agilent Technologies, Inc. has a 52-week low of $42.92 and a 52-week high of $66.42. The company’s 50-day moving average price is $62.40 and its 200-day moving average price is $58.01. The firm has a market capitalization of $21.23 billion, a P/E ratio of 34.02 and a beta of 1.30.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Tuesday, August 15th. The medical research company reported $0.59 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.52 by $0.07. The firm had revenue of $1.11 billion for the quarter, compared to analysts’ expectations of $1.09 billion. Agilent Technologies had a net margin of 14.36% and a return on equity of 16.95%. The business’s revenue was up 6.7% on a year-over-year basis. During the same period in the prior year, the firm earned $0.49 EPS. On average, equities research analysts expect that Agilent Technologies, Inc. will post $2.32 EPS for the current fiscal year.

Several equities analysts have weighed in on A shares. Deutsche Bank AG raised their target price on Agilent Technologies from $58.00 to $62.00 and gave the company a “buy” rating in a report on Monday, May 22nd. Cowen and Company raised their price target on Agilent Technologies from $53.00 to $62.00 and gave the company a “market perform” rating in a research report on Tuesday, May 23rd. Jefferies Group LLC raised their price target on Agilent Technologies from $59.00 to $66.00 and gave the company a “buy” rating in a research report on Tuesday, May 23rd. Robert W. Baird raised their price target on Agilent Technologies from $57.00 to $62.00 and gave the company an “outperform” rating in a research report on Wednesday, May 24th. Finally, BTIG Research raised their price target on Agilent Technologies from $57.00 to $65.00 and gave the company a “buy” rating in a research report on Wednesday, May 24th. Three analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. Agilent Technologies presently has a consensus rating of “Buy” and an average target price of $63.91.

TRADEMARK VIOLATION WARNING: This piece of content was reported by Daily Political and is the property of of Daily Political. If you are accessing this piece of content on another domain, it was illegally stolen and republished in violation of U.S. & international copyright and trademark laws. The legal version of this piece of content can be accessed at https://www.dailypolitical.com/2017/09/17/norinchukin-bank-the-purchases-1440-shares-of-agilent-technologies-inc-a.html.

In other Agilent Technologies news, CEO Michael R. Mcmullen sold 16,492 shares of the stock in a transaction dated Thursday, September 14th. The shares were sold at an average price of $65.33, for a total value of $1,077,422.36. Following the transaction, the chief executive officer now directly owns 211,872 shares of the company’s stock, valued at approximately $13,841,597.76. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CFO Didier Hirsch sold 72,545 shares of the stock in a transaction dated Tuesday, August 22nd. The shares were sold at an average price of $62.38, for a total transaction of $4,525,357.10. The disclosure for this sale can be found here. Over the last three months, insiders sold 155,165 shares of company stock worth $9,768,409.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.